Eco-friendly synthesis and antimicrobial activities of some 1-phenyl-3(5-bromothiophen-2-yl)-5-(substituted phenyl)-2-pyrazolines. 2012

Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
Department of Chemistry, Annamalai University, Annamalai, Nagar 608 002, India. drgtnarayanan@gmail.com.

BACKGROUND Green catalyst fly ash: H2SO4 was prepared by mixing fly ash and sulphuric acid. Microwave irradiations are applied for solid phase cyclization of 5-bromo-2-thienyl chalcones and phenyl hydrazine hydrate in the presence of fly ash: H2SO4 yields, 1-phenyl-3(5-bromothiophen-2-yl)-5-(substituted phenyl)-2-pyrazolines. These pyrazolines were characterized by their physical constants and spectral data. The antimicrobial activities of all synthesized pyrazolines have been studied. RESULTS Scanning electron microscopy (SEM) analysis shows the morphology changes between fly ash and the catalyst fly ash: H2SO4. The SEM photographs with the scale of 1 and 50 μm show the fly-ash particle is corroded by H2SO4 (indicated by arrow mark), and this may be due to dissolution of fly ash by H2SO4. The yields of 1-phenyl-3(5-bromothiophen-2-yl)-5-(substituted phenyl)-2-pyrazolines is more than 75% using this catalyst under microwave heating. All pyrazolines showed moderate activities against antimicrobial strains. CONCLUSIONS We have developed an efficient catalytic method for synthesis of 1-phenyl-3(5-bromothiophen-2-yl)-5-(substituted phenyl)-2-pyrazolines by solid phase cyclization using a solvent-free environmentally greener catalyst fly ash: H2SO4 under microwave irradiation between aryl chalcones and hydrazine hydrate. This reaction protocol offers a simple, economical, environment friendly, non-hazardous, easier work-up procedure, and good yields. All synthesized pyrazoline derivatives showed moderate antimicrobial activities against bacterial and fungal strains.

UI MeSH Term Description Entries

Related Publications

Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
September 2005, European journal of medicinal chemistry,
Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
June 2002, Archiv der Pharmazie,
Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
March 2005, Archiv der Pharmazie,
Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
October 2011, Journal of enzyme inhibition and medicinal chemistry,
Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
August 2003, Archiv der Pharmazie,
Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
January 1988, Die Pharmazie,
Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
March 2002, Farmaco (Societa chimica italiana : 1989),
Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
January 2012, Acta poloniae pharmaceutica,
Ramalingam Sasikala, and Kannan Thirumurthy, and Perumal Mayavel, and Ganesamoorthy Thirunarayanan
June 2013, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!